#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15246	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2470	758.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1823	1823	T	978	T,C,G,A	973,3,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15246	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2470	758.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1557	1557	C	997	C,T,A	995,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25256	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4024	782.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1905	1905	A	1050	A,G,C	1048,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25256	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4024	782.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2539	2539	C	917	C,G	916,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25256	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4024	782.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3165	3165	T	867	T,G	866,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25256	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4024	782.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2613	2613	A	819	A,C	818,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25256	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4024	782.9	0	HET	.	.	.	C1344T,A	.	1344	1344	C	1912	1912	C	1027	C,T,A	791,234,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	2336	folP	852	852	99.88	folP.l15.c4.ctg.1	2054	141.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	183.6	1	SNP	p	S91F	0	.	.	271	273	TCC	761	763	TCC	200;198;197	T;C;C	200;198;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	183.6	1	SNP	p	D95N	0	.	.	283	285	GAC	773	775	GAC	205;205;205	G,C;A,C;C,A	204,1;204,1;204,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	183.6	1	SNP	p	D95G	0	.	.	283	285	GAC	773	775	GAC	205;205;205	G,C;A,C;C,A	204,1;204,1;204,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1850	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1595	144.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	610	612	ACC	218;218;219	A;C;C	218;218;219	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1850	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1595	144.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	808	810	CAC	244;244;241	C;A;C,A	244;244;240,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1850	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1595	144.0	0	.	p	.	0	E117K	NONSYN	349	351	GAA	844	846	AAA	223;220;220	A;A,C;A	223;219,1;220	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1850	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1595	144.0	1	SNP	p	G45D	0	.	.	133	135	GGC	628	630	GGC	223;224;225	G;G;C	223;224;225	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1154	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1322	108.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1880	1882	GCA	241;242;245	G;C;A	241;242;245	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2363	2365	ATT	246;248;249	A;T,C;T,G	246;247,1;248,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	1	SNP	p	D86N	0	.	.	256	258	GAC	833	835	GAC	239;233;231	G,T;A;C	238,1;233;231	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	1	SNP	p	S87W	0	.	.	259	261	AGT	836	838	AGT	231;232;231	A;G;T	231;232;231	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	1	SNP	p	S87R	0	.	.	259	261	AGT	836	838	AGT	231;232;231	A;G;T	231;232;231	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	1	SNP	p	S87I	0	.	.	259	261	AGT	836	838	AGT	231;232;231	A;G;T	231;232;231	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5154	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	189.1	1	SNP	p	S88P	0	.	.	262	264	TCC	839	841	TCC	230;229;232	T,A;C,A;C	228,2;228,1;232	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4496	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2922	191.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1734	1736	GGC	254;254;252	G;G,A,T;C	254;252,1,1;252	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1533	1535	GCA	255;253;253	G,T;C,A;A,T	254,1;252,1;252,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1536	1538	ATC	255;254;255	A;T,G;C	255;253,1;255	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1548	1550	GTG	248;249;250	G,T;T,A;G,C	247,1;247,2;249,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1548	1550	GTG	248;249;250	G,T;T,A;G,C	247,1;247,2;249,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2052	2054	ACC	213;215;217	A;C;C,A	213;215;216,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2106	2108	GCG	261;259;261	G;C;G	261;259;261	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2106	2108	GCG	261;259;261	G;C;G	261;259;261	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2229	2231	GGT	217;215;212	G,T;G;T	216,1;215;212	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2238	2240	GGC	214;214;213	G;G;C,A	214;214;212,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4152	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2923	177.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2256	2258	CCG	219;215;211	C;C;G,T	219;215;209,2	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5922	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3579	206.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1790	1792	CTG	257;255;253	C;T;G,C	257;255;252,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2442	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2203	138.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	755	755	C	204	C	204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	868	870	CAA	235;240;243	C,G;A,G;A	234,1;239,1;243	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1075	1077	GGT	226;225;223	G;G,T;T	226;224,1;223	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1078	1080	GAT	224;223;224	G;A,T;T,A,C	224;222,1;222,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1084	1086	GCT	225;222;223	G,T;C,T;T	224,1;221,1;223	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1093	1095	ATG	221;222;222	A,T;T;G	220,1;222;222	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1210	1212	AAG	234;234;238	A;A;G	234;234;238	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2886	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1657	213.0	1	SNP	p	G120K	0	.	.	358	360	GGC	799	801	GGC	244;243;241	G;G;C,G	244;243;240,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9930	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5432	228.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2264	2266	CAT	253;253;251	C,A;A,G;T	252,1;252,1;251	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1520	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1373	137.6	1	SNP	p	V57M	0	.	.	169	171	GTG	677	679	GTG	248;245;243	G;T;G	248;245;243	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
